Upstream Bio, Inc.
UPB
$9.71
$0.9310.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -32.83% | -25.07% | 0.00% | -8.05% | -281.46% |
| Total Depreciation and Amortization | 250.00% | 7.69% | 0.00% | -7.14% | -17.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 123.17% | 202.85% | 0.00% | -380.23% | 94.51% |
| Change in Net Operating Assets | -283.82% | -42.04% | 0.00% | 130.71% | -231.76% |
| Cash from Operations | -40.47% | -9.09% | 0.00% | 20.55% | -234.30% |
| Capital Expenditure | 43.25% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,326.11% | 103.38% | 0.00% | -880.56% | -142.80% |
| Cash from Investing | 2,874.31% | 102.74% | 0.00% | -880.56% | -142.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,435,431.58% | -66.07% | 0.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | 0.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -166.00% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -31.20% | -2,396.24% | 0.00% | -- | -- |
| Cash from Financing | 16,592.87% | -102.19% | 0.00% | 56,454.51% | -366.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,163.86% | -232.02% | 0.00% | 150.04% | -387.23% |